Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)

Gynecologic Oncology

Volumn 51, Issue 2, 1993, Pages 197-204

  Hubner, Karl F ^a   McDonald, Thomas W ^a   Niethammer, John G ^a   Smith, Gary T ^a   Gould, Howard R ^a   Buonocore, Edward ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0027742047     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1993.1272     Document Type: Article

References (20)

1. Warde, P., Ridenour, D. F., and Herman, S., Computed tomography in advanced ovarian cancer: Inter-and intraobserver reliability, Invest. Radiol. 21, 31-33 (1986).
2. Buy, J-N., Ghossian, M. A., Sciot, C., Bazot, M., Guinet, C., Prevot, S., Hugol, D., Laromiguiere, M., True, J. B., Poitout, P., Vadrot, D., and Ecoiffier, J., Epithelial tumors of the ovary: CT findings and correlation with US, Radiology 178, 811 (1991).
3. Nelson, B. E., Rosenfield, A., and Schwartz, P. E. Preoperative abdominopelvic computed tomographic prediction of optimal cy-toreduction in epithelial ovarian carcinoma, J. Clin. Oncol. 11 (1), 166-172 (1993).
4. Lund, B., Jacobsen, K., and Rasch, I. Correlation of abdominal ultrasound and computed tomography scans with second-or third-look laparotomy in patients with ovarian carcinoma, Gynecol. Oncol. 37, 279-283 (1990).
5. Pectasides, D., Kayianni, H., Facou, A., Bobotas, N., Barbounis, V., Zis, J., and Athanassiou, A. Correlation of abdominal computed tomography scanning and second-look operation findings in ovarian cancer patients, Am. J. Clin. Oncol. 14(6), 457-462 (1991).
6. Einhorn, N., Nilsson, B., and Stovall, K. Factors influencing survival in carcinoma of the ovary, Cancer 55, 2015-2019 (1985).
7. Rubin, S. C., and Lewis, J. L Second-look surgery in ovarian carcinoma, CRC Crit. Rev. Oncol. Hematol. 8, 75-91 (1988).
8. Strauss, L. G., and Conti, P. S. The applications of PET in clinical oncology, J. Hud. Med. 32, 623-648 (1991).
9. Council on Scientific Affairs. Positron emission tomography in oncology, J. Am. Med. Assoc. 259, 2126-2131 (1988).
10. Hawkins, R. A., and Phelps, M. E. PET in clinical oncology, Cancer Met. Rev. 7, 119-142 (1988).
11. Larson, S. M. Positron emission tomography in oncology and allied diseases, Princ. Pract. Oncol. Updates 3, 1-12 (1989).
12. Beaney, R. P. Positron emission tomography of human tumors, Semin. Nucl. Med. 14, 324-341 (1984).
13. Beaney, R. P. Positron emission tomography in oncology, Clin. Oncol. 5, 199-222 (1986).
14. Wahl, R. L., Hutchins, G., and Roberts, J., PET imaging of ovarian cancer: Initial evaluation in patients, J. Nucl. Med. 32(5), 982 (1991). [Abstract No. 310].
15. Gupta, N. C., Frank, A. R., Casey, M. J., Rysavy, J., Sunderland, J., Terry, J. D., and Frick, M. P., FDG PET imaging for posttreatment evaluation of patients with genitourinary (GU) malignancies, J. Nucl. Med. 33, 829 (1992).
16. Gupta, N., Muths, C., Casey, M., Frank, A., Terry, J., and Chan-dramouli, B. Detection of residual/recurrent ovarian cancer using PET-FDG imaging, J. Nucl. Med. 34, 16, 7P (1993). [Abstract].
17. Warburg, O. H. Über den Stoffwechsel der Tumoren, Springer, Berlin (1926).
18. Fuhr, J. E., Frye, A., Katrine, A, A. and Van Meter, S. Flow cytometric determination of breast tumor heterogeneity, Cancer 67, 1401-1405 (1991).
19. Dahlbom, M., Hoffman, E. J., Hoh, C. K., Schiepers, C., Rosenqvist, G., Hawkins, R. A., and Phelps, M. E. Evaluation of a positron emission tomography (PET) scanner for whole body imaging, J. Nucl. Med. 33, 1191-1199 (1992).
20. Krag, D. N. Antibody imaging for ovarian cancer, Appl. Radiol. April, 30-33 (1992).